COLORCON LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about COLORCON LIMITED
Live alerts from global media, monitored by Business Radar
2024-08-13 (contractpharma.com)
Colorcon, Inc. |
Colorcon Acquires Indian Coatings Business
Read more
2024-06-05 (indiashorts.com)
Healthcare Packaging Market Size to Exceed USD 229.91 Billion by 2032
The global healthcare packaging market size is calculated at USD 145.08 billion in 2024 and is expected to exceed around USD 229.91 billion by 2032, a study published by Towards Packaging a sister firm of Precedence Research.Ottawa, June 05, 2024 (GL
Read more
2023-03-02 (prnewswire.com)
Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging
/PRNewswire/ -- Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces that it has completed the acquisition...
Read more
2021-10-15 (privateequitywire.co.uk)
Colorcon acquires majority Share in Ideal Cures
Colorcon, a specialist in pharmaceutical film coatings and specialty excipients, has acquired a majority share in Ideal Cures, a manufacturer of excipients and ready-to-use coating systems for solid oral dosage forms located in India.
Read more
2021-10-15 (privateequitywire.co.uk)
Colorcon acquires majority Share in Ideal Cures
Colorcon, a specialist in pharmaceutical film coatings and specialty excipients, has acquired a majority share in Ideal Cures, a manufacturer of excipients and ready-to-use coating systems for solid oral dosage forms located in India.
Read more
2021-10-14 (economictimes.com)
Colorcon buys TA-backed pharma firm Ideal Cures
TA Associates, which has invested in more than 500 companies around the globe, has a wide exposure in India with investments such as Indira IVF, Dr Lal Pathlabs, OmniActive and TCNS Clothing which sells W brand.
Read more
2021-10-14 (economictimes.com)
Colorcon buys TA-backed pharma firm Ideal Cures
TA Associates, which has invested in more than 500 companies around the globe, has a wide exposure in India with investments such as Indira IVF, Dr Lal Pathlabs, OmniActive and TCNS Clothing which sells W brand.
Read more
2021-10-14 (indiatimes.com)
Colorcon buys TA-backed pharma firm Ideal Cures
TA Associates, which has invested in more than 500 companies around the globe, has a wide exposure in India with investments such as Indira IVF, Dr Lal Pathlabs, OmniActive and TCNS Clothing which sells W brand.
Read more
2021-10-14 (lvb.com)
Colorcon acquires majority stake in India pharmaceutical manufacturer
Harleysville-based Colorcon Inc., a manufacturer of pharmaceutical film coatings and specialty excipients has purchased a majority share in Ideal Cures Pvt.
Read more
2021-10-13 (finsmes.com)
Remedy Health Receives Investment from Colorcon Ventures
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Read more
2019-09-18 (finsmes.com)
Colorcon Launches $50M Colorcon Ventures - FinSMEs
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Read more
2019-04-22 (outsourcing-pharma.com)
Colorcon expands coating portfolio with DuPont’s Aquacoat
Colorcon adds DuPont’s Aquacoat technology, held in CR Alliance’s portfolio, whilst planning to transition existing customers over to the company.
Read more